These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16715384)

  • 1. Chitosan-modified dry powder formulations for pulmonary gene delivery.
    Li HY; Birchall J
    Pharm Res; 2006 May; 23(5):941-50. PubMed ID: 16715384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced dispersibility and deposition of spray-dried powders for pulmonary gene therapy.
    Li HY; Neill H; Innocent R; Seville P; Williamson I; Birchall JC
    J Drug Target; 2003 Aug; 11(7):425-32. PubMed ID: 15203931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of absorption enhancers to enhance the dispersibility of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Aug; 7(8):1035-43. PubMed ID: 15756712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-viral dried powders for respiratory gene delivery prepared by cationic and chitosan loaded liposomes.
    Colonna C; Conti B; Genta I; Alpar OH
    Int J Pharm; 2008 Nov; 364(1):108-18. PubMed ID: 18775770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying.
    Seville PC; Kellaway IW; Birchall JC
    J Gene Med; 2002; 4(4):428-37. PubMed ID: 12124985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of formulation components on the aerosolisation properties of spray-dried powders.
    Rabbani NR; Seville PC
    J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Mar; 7(3):343-53. PubMed ID: 15515142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
    Sinsuebpol C; Chatchawalsaisin J; Kulvanich P
    Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
    Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
    Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lactose carrier on the powder behavior and aerodynamic performance of bosentan microparticles for dry powder inhalation.
    Lee HJ; Lee HG; Kwon YB; Kim JY; Rhee YS; Chon J; Park ES; Kim DW; Park CW
    Eur J Pharm Sci; 2018 May; 117():279-289. PubMed ID: 29510172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers.
    Lucas P; Anderson K; Staniforth JN
    Pharm Res; 1998 Apr; 15(4):562-9. PubMed ID: 9587952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation.
    Mohri K; Okuda T; Mori A; Danjo K; Okamoto H
    J Control Release; 2010 Jun; 144(2):221-6. PubMed ID: 20184930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of operating and formulation variables on the morphology of spray-dried protein particles.
    Maa YF; Costantino HR; Nguyen PA; Hsu CC
    Pharm Dev Technol; 1997 Aug; 2(3):213-23. PubMed ID: 9552449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.
    Sham JO; Zhang Y; Finlay WH; Roa WH; Löbenberg R
    Int J Pharm; 2004 Jan; 269(2):457-67. PubMed ID: 14706257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
    Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
    J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation.
    Pilcer G; Sebti T; Amighi K
    Pharm Res; 2006 May; 23(5):931-40. PubMed ID: 16715383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery.
    Zeng XM; Martin GP; Marriott C; Pritchard J
    J Pharm Sci; 2001 Sep; 90(9):1424-34. PubMed ID: 11745794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders.
    Wanning S; Süverkrüp R; Lamprecht A
    Int J Pharm; 2020 Aug; 586():119564. PubMed ID: 32590097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.